tirzepatide and type 2 diabetes Tirzepatide: A novel cardiovascular protective agent in mellitus obesity Mounjaro and Type 2 Diabetes:
Description
The two conditions share overlapping pathophysiological mechanisms, including systemic inflammation, endothelial dysfunction, and atherosclerosis [178]
Fasting Blood Sugar: Along with A1C, fasting blood sugar levels also show significant improvement
Digestive and Liver Disease
GLP-1 receptor agonists reduce gallbladder motility
